1. Home
  2. SLXN vs RELI Comparison

SLXN vs RELI Comparison

Compare SLXN & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • RELI
  • Stock Information
  • Founded
  • SLXN 2008
  • RELI 2013
  • Country
  • SLXN Israel
  • RELI United States
  • Employees
  • SLXN N/A
  • RELI N/A
  • Industry
  • SLXN
  • RELI Specialty Insurers
  • Sector
  • SLXN
  • RELI Finance
  • Exchange
  • SLXN NYSE
  • RELI Nasdaq
  • Market Cap
  • SLXN 3.0M
  • RELI 2.7M
  • IPO Year
  • SLXN N/A
  • RELI N/A
  • Fundamental
  • Price
  • SLXN $0.21
  • RELI $1.45
  • Analyst Decision
  • SLXN Strong Buy
  • RELI Strong Buy
  • Analyst Count
  • SLXN 1
  • RELI 1
  • Target Price
  • SLXN $1.00
  • RELI $119.00
  • AVG Volume (30 Days)
  • SLXN 1.5M
  • RELI 79.1K
  • Earning Date
  • SLXN 11-14-2024
  • RELI 11-07-2024
  • Dividend Yield
  • SLXN N/A
  • RELI N/A
  • EPS Growth
  • SLXN N/A
  • RELI N/A
  • EPS
  • SLXN N/A
  • RELI N/A
  • Revenue
  • SLXN N/A
  • RELI $14,078,473.00
  • Revenue This Year
  • SLXN N/A
  • RELI N/A
  • Revenue Next Year
  • SLXN N/A
  • RELI N/A
  • P/E Ratio
  • SLXN N/A
  • RELI N/A
  • Revenue Growth
  • SLXN N/A
  • RELI 4.71
  • 52 Week Low
  • SLXN $0.21
  • RELI $1.42
  • 52 Week High
  • SLXN $13.56
  • RELI $24.14
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • RELI 21.28
  • Support Level
  • SLXN N/A
  • RELI $2.17
  • Resistance Level
  • SLXN N/A
  • RELI $2.40
  • Average True Range (ATR)
  • SLXN 0.00
  • RELI 0.20
  • MACD
  • SLXN 0.00
  • RELI -0.07
  • Stochastic Oscillator
  • SLXN 0.00
  • RELI 2.57

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: